Rainbow Children's Medicare Declares Q1 FY27 Results; Appoints Anshuman Jaiswal as Chief Legal Officer
Rainbow Children's Medicare reported Q1 FY27 results with consolidated revenue at ₹469.99 crore and PAT at ₹625.40 crore. Mr. Anshuman Jaiswal was appointed Chief Legal Officer. The company is also set to acquire a hospital in Nellore for ₹19.8 crore, with completion expected in Q2 FY27.
The appointment of a Chief Legal Officer is a significant management change. The financial results and strategic acquisitions are material events that will impact the company's future performance and market position.
The company reported strong financial results and made a key management appointment, indicating positive operational and strategic progress. The acquisitions also signal growth.
Rainbow Children's Medicare Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's Board of Directors also approved the elevation of Mr. Anshuman Jaiswal to the position of Chief Legal Officer and designated him as Senior Management Personnel (SMP) with immediate effect.
The Board Meeting, held on July 30, 2026, reviewed and approved the financial results. For the quarter ended June 30, 2026, the standalone revenue from operations stood at ₹410.55 crore (4,105.47 million) and profit after tax was ₹527.06 crore (5,270.6 million).
On a consolidated basis, revenue from operations for the quarter was ₹469.99 crore (4,699.85 million) with a profit after tax of ₹625.40 crore (6,254.0 million).
Mr. Anshuman Jaiswal, an alumnus of NALSAR University of Law with over two decades of experience, was elevated from Group Head – Legal. His prior roles include partnerships at Amarchand Mangaldas and Cyril Amarchand Mangaldas, and Senior Vice President at Greenko Group.
Subsequent to the quarter end, the company has also executed definitive transaction documents for a new hospital in Malad, Mumbai, expected to be completed in Q2 FY27. Additionally, an agreement was executed for the acquisition of a 64% partnership interest in Super Prime Medical Care LLP for ₹19.8 crore (198 million), which will result in the acquisition of a running children's hospital in Nellore, Andhra Pradesh, also expected to be completed in Q2 FY27.
The Board Meeting commenced at 12:30 PM and concluded at 4:00 PM on July 30, 2026.
What to do with a filing like this
Rainbow Childrens Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rainbow Childrens Medicare Limited. Read the original for the full detail.